Abeona Therapeutics (ABEO) Return on Equity (2016 - 2025)
Historic Return on Equity for Abeona Therapeutics (ABEO) over the last 15 years, with Q3 2025 value amounting to 0.21%.
- Abeona Therapeutics' Return on Equity rose 10700.0% to 0.21% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.21%, marking a year-over-year increase of 10700.0%. This contributed to the annual value of 2.32% for FY2024, which is 400.0% down from last year.
- Per Abeona Therapeutics' latest filing, its Return on Equity stood at 0.21% for Q3 2025, which was up 10700.0% from 0.39% recorded in Q2 2025.
- Abeona Therapeutics' Return on Equity's 5-year high stood at 0.39% during Q2 2025, with a 5-year trough of 17.06% in Q1 2024.
- Moreover, its 5-year median value for Return on Equity was 1.53% (2021), whereas its average is 2.76%.
- Per our database at Business Quant, Abeona Therapeutics' Return on Equity tumbled by -151700bps in 2024 and then surged by 156200bps in 2025.
- Over the past 5 years, Abeona Therapeutics' Return on Equity (Quarter) stood at 1.53% in 2021, then plummeted by -72bps to 2.64% in 2022, then grew by 2bps to 2.58% in 2023, then skyrocketed by 52bps to 1.24% in 2024, then skyrocketed by 117bps to 0.21% in 2025.
- Its Return on Equity was 0.21% in Q3 2025, compared to 0.39% in Q2 2025 and 1.44% in Q1 2025.